Impact of the spread of COVID-19 on healthcare facilities and contract service fees
First written in FY2020. 9 of 12 entries say "Restated". Latest entry: FY2026.
GLOME Holdings moved to the "Worse" side of this theme in 2024, 1 year before the typical company in this theme (2025).
0 other companies' latest entry also says "Reframed".
- FY2026ReframedAnnual report
「Under the current social conditions, the response to COVID-19 has shifted to normal operations, and the series of measures has reached a conclusion.」
The description of the infectious disease response has shifted to one premised on normal operations and the containment phase following the move to Category 5, while the risk of an outbreak affecting healthcare facilities and contract service fees continues to be disclosed. - FY2024ReframedAnnual report
「Since 8 May 2023, COVID-19 has been classified as a Category 5 infectious disease under the Act on the Prevention of Infectious Diseases and Medical Care for Patients with Infectious Diseases (Act No. 114 of 1998). While giving top priority to preventing officers and employees of our Group from bringing the virus into alliance healthcare facilities, including prospective partners, and to the safety of all officers and employees of our Group, including those at alliance healthcare facilities, we will advance Group-wide measures against infectious diseases, including providing training and lectures and maintaining equipment and supplies throughout the Group.」
Infectious disease risk continues, but following the transition to Category 5 infectious diseases, the response is described as a company-wide effort that includes not only preventing infections from being brought into facilities but also training, lectures and equipment maintenance. - FY2023-Q3RestatedAnnual report
「We will continue to closely monitor the impact of COVID-19 on our business.」
The stance of continuing to monitor the impact of COVID-19 on the business has been reaffirmed. - FY2023-Q2RestatedAnnual report
「We will continue to closely monitor the impact of COVID-19 on our business.」
The stance of continuing to monitor the impact of COVID-19 on the business has been reiterated, and no new risks or material changes are reported. - FY2023-Q1RestatedAnnual report
「We will continue to closely monitor the impact of COVID-19 on our business.」
The stance of continuing to monitor the impact of COVID-19 on the business has been reiterated, and it is stated that there are no new risks or material changes. - FY2022RestatedAnnual report
「While giving top priority to preventing officers and employees of our Group from bringing the virus into alliance healthcare facilities, including prospective partners, and to the safety of all officers and employees of our Group, including those at alliance healthcare facilities」
The risk that infectious diseases could affect the medical services, business conditions and contract service fees of affiliated healthcare facilities, together with the continued priority placed on safety, remains. - FY2022-Q1RestatedAnnual report
「We will continue to closely monitor the impact of COVID-19 on our business.」
The stance of continuing to closely monitor the impact of COVID-19 on the business has been reiterated. - FY2021RestatedAnnual report
「Particularly if officers, employees or patients at an alliance healthcare facility become infected, this may adversely affect the facility's medical services and other operations and cause its business performance to deteriorate. In such cases, revenue from contract service fees and other payments from the relevant medical corporation may become unstable for our Group, potentially weakening our financial position.」
The risk that the spread of COVID-19 could affect healthcare facilities' medical services, business performance and contract service fees continues. - FY2021-Q3RestatedAnnual report
「The timing of the containment of COVID-19 remains uncertain. We will continue to closely monitor the situation.」
The stance of continuing to monitor the uncertain situation regarding the containment of COVID-19 and its impact on the business has been reiterated. - FY2021-Q2RestatedAnnual report
「We will continue to closely monitor the impact of COVID-19 on our business.」
The stance of continuing to closely monitor the impact of COVID-19 on the business has been reiterated. - FY2021-Q1RestatedAnnual report
「The business environment remains one requiring caution regarding the impact of COVID-19, and the situation remains unpredictable.」
The impact of COVID-19 on the business environment is said to be continuing, and the risk section states that the situation will continue to be closely monitored. At the same time, it is explained that the hospital business has not experienced any major direct impact. - FY2020First statedAnnual report
「Particularly if patients or healthcare professionals at an alliance hospital or other facility become infected, the financial impact and management risks to that healthcare facility may not be fully avoidable. In such cases, revenue from contract service fees and other payments from the relevant medical corporation may become unstable for our Group as well.」
The risk that infections such as COVID-19 could destabilize the operations of alliance medical corporations and our contract service fee revenue was documented separately for the first time.